Loading patent…
AssigneeKorea Food Research Institute
InventorsHo Young Park, Yoon Sook Kim, Sang Hoon Lee, Sang Keun Ha, So Young Lee, Mi Jin Oh
Estimating the term…
The present invention relates to a novel strain having the activity of reducing advanced glycation end products and a use thereof and, more particularly, to a food composition having the activity of reducing advanced glycation end products and a pharmaceutical composition for preventing or treating a disease caused by advanced glycation end products each of which comprises a Lactococcus lactis KF140 (accession number KCCM11673P) strain, a Bacillus subtilis KF11 (accession number KCCM11981P) strain, a Lactobacillus pentosus KF8 (accession number KCCM11997P) strain, or a Lactobacillus paracasei KF00816 (accession number KCCM11998P) strain, which are all novel strains; a lysate thereof; or a culture thereof as an active ingredient. In addition, the present invention relates to a composition for intestinal regulation, a probiotic composition, a feed composition, and a fermented product, each of which comprises the novel strain of the present invention, a lysate thereof, or a culture thereof as an active ingredient.
A method for inhibiting advanced glycation end products (AGEs), the method comprising administering a novel strain, a lysate thereof, or a culture thereof to a subject in need thereof,
A method of reducing Nε-(carboxymethyl) lysine (CML), the method comprising administering a novel strain, a lysate thereof, or a culture thereof to a subject in need thereof,
Dependencies are inferred from the claim text.